Impact of the duration of renal replacement therapy on the respiratory complications in patients with end-stage renal disease

O. Shtepa (Dnipro, Ukraine), O. Kuryata (Dnipro, Ukraine), O. Halushchak (Dnipro, Ukraine)

Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Session: Paediatrics and Quality of life
Session type: Poster Discussion
Number: 121
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Shtepa (Dnipro, Ukraine), O. Kuryata (Dnipro, Ukraine), O. Halushchak (Dnipro, Ukraine). Impact of the duration of renal replacement therapy on the respiratory complications in patients with end-stage renal disease. Respiratory Failure and Mechanical Ventilation Conference 2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of hemodialysis on dyspnoea in chronic renal failure patients
Source: Annual Congress 2011 - Clinical physiology for clinical problems
Year: 2011

Impact of hemodialysis on dyspnoea and lung function in patients with chronic renal failure
Source: Annual Congress 2008 - Lung function in respiratory disease
Year: 2008

Pleuro-pulmonary changes in patients suffering from end-stage renal disease receiving regular hemodialysis
Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases
Year: 2011


Functional assessment of respiration before and after hemodialysis in patients with chronic renal failure
Source: Eur Respir J 2006; 28: Suppl. 50, 201s
Year: 2006

Effects of physiotherapy intervention in chronic renal failure patients during hemodialysis
Source: Annual Congress 2010 - Exercise training: new groups, new methods and outcomes
Year: 2010


Pulmonary function in patients with end-stage renal disease and renal transplant recipients
Source: Eur Respir J 2004; 24: Suppl. 48, 56s
Year: 2004

Characteristics of pneumonia course at the patients with renal insufficiency receiving hemodialysis
Source: Annual Congress 2010 - Unusual pathogens in respiratory infections
Year: 2010

Pulmonary hypertension in end-stage renal disease and post renal transplantation patients
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013


Effect of the type of end-stage lung disease on postoperative evolution of lung transplantation patients
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012


Side-effects of antituberculosis drug treatment in patients with chronic renal failure
Source: Eur Respir J 2002; 20: 440-443
Year: 2002



Extrapulmonary tuberculosis in patients with chronic kidney disease receiving renal replacement therapy
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019


Short-term systemic steroid therapy in chronic obstructive pulmonary disease patients with acute respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020



Tuberculosis in patients with chronic renal failure
Source: Eur Respir J 2006; 28: Suppl. 50, 164s
Year: 2006

Relationship between renal correction with chronic respiratory acidosis and prognosis in patients with chronic respiratory failure
Source: Virtual Congress 2020 – Home non-invasive ventilation: (long-term) effects and prognosis
Year: 2020


Acute effects of early mobility and respiratory therapy in hospitalised patients with chronic heart failure
Source: Annual Congress 2009 - Respiratory physiotherapy assessment
Year: 2009


Enhanced chemo-responsiveness in patients with sleep apnoea and end-stage renal disease
Source: Eur Respir J 2006; 28: 151-158
Year: 2006



The prospective impact of chronic obstructive pulmonary disease on short-term prognosis of patients with chronic heart failure
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension
Source: Annual Congress 2010 - COPD: management
Year: 2010

Short-term outcomes in community heart failure patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Comorbidities and management in primary care
Year: 2011

Predictors of survival of patients with chronic obstructive pulmonary disease in long-term oxygen therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 519s
Year: 2006